The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Authors
Keywords
COVID-19, Quercetin, Remdesivir, Favipiravir
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 914, Issue -, Pages 174615
Publisher
Elsevier BV
Online
2021-12-03
DOI
10.1016/j.ejphar.2021.174615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
- (2021) Hany M. Dabbous et al. ARCHIVES OF VIROLOGY
- Major Update: Remdesivir for Adults With COVID-19
- (2021) Anjum S. Kaka et al. ANNALS OF INTERNAL MEDICINE
- Anti-inflammatory potential of Quercetin in COVID-19 treatment
- (2021) Ali Saeedi-Boroujeni et al. Journal of Inflammation-London
- Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients
- (2021) Judith Marín-Corral et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
- (2021) Nicolas Hoertel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study
- (2021) Anıl Ucan et al. Virology Journal
- Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis
- (2021) Surjit Singh et al. BMJ Open
- Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
- (2021) Francesco Di Pierro et al. International Journal of General Medicine
- Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
- (2021) Francesco Di Pierro et al. International Journal of General Medicine
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Partners in Crime: The Interplay of Proteins and Membranes in Regulated Necrosis
- (2020) Uris Ros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe COVID-19: NLRP3 Inflammasome Dysregulated
- (2020) Daan F. van den Berg et al. Frontiers in Immunology
- Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)
- (2020) Ruben Manuel Luciano Colunga Biancatelli et al. Frontiers in Immunology
- Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells
- (2020) Gennadi V. Glinsky Biomedicines
- A role for quercetin in coronavirus disease 2019 (COVID‐19)
- (2020) Giuseppe Derosa et al. PHYTOTHERAPY RESEARCH
- The Immune Response and Immunopathology of COVID-19
- (2020) Esmaeil Mortaz et al. Frontiers in Immunology
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
- (2020) Eric J. Lenze et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations
- (2020) Pawan K. Agrawal et al. Natural Product Communications
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion
- (2016) Virginia Chamorro et al. MOLECULES
- Quercetin, Inflammation and Immunity
- (2016) Yao Li et al. Nutrients
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started